By Ishioma Appiah-Yeboah
A silent but rapidly escalating global health crisis is drawing urgent attention as Nigeria prepares to host world leaders for a high-level summit on antimicrobial resistance (AMR), a threat experts say is already responsible for millions of deaths each year.
Known scientifically as Antimicrobial Resistance, the phenomenon occurs when life-saving medicines lose their ability to treat infections, turning once-manageable illnesses into potentially fatal conditions. From minor infections to routine surgical procedures, the risks are intensifying worldwide.
A Growing Global Crisis
Health experts warn that the surge in drug resistance is largely driven by the misuse and overuse of antibiotics, antivirals, antifungals, and antiparasitic drugs across human medicine, livestock production, and agriculture.
At a recent global media briefing, Jean Pierre Nyemazi described AMR as one of the most pressing public health threats of the 21st century, with low- and middle-income countries bearing the heaviest burden.
“When medicines stop working, even the simplest infections can become deadly,” he warned.
Current estimates link nearly five million deaths globally to drug-resistant infections, prompting an international target to reduce such fatalities by at least 10 percent before 2030. Experts say improved hygiene, responsible drug use, and stronger healthcare systems remain critical to slowing the trend.
Beyond Health: A Multi-Sectoral Threat
The impact of AMR now extends far beyond hospitals.
It affects food systems, animal health, environmental sustainability, and national economies—making it a complex, multi-sectoral crisis.
Shobha Shukla, Chairperson of the Global AMR Media Alliance, warned that widespread misuse of medicines in agriculture and livestock production is accelerating resistance.
She described AMR as a growing equity issue, noting that vulnerable populations face higher risks due to weak health systems, limited diagnostic capacity, and poor regulation of drug distribution.
Nigeria Takes Centre Stage
Against this backdrop, Nigeria will host the Fifth High-Level Ministerial Meeting on AMR in Abuja from June 28 to 30, 2026, bringing together delegates from more than 100 countries.
The meeting, themed “One Health: Advancing Global AMR Commitments through Local Action,” will include major international organisations such as the World Health Organization, Food and Agriculture Organization, United Nations Environment Programme, and the World Organisation for Animal Health.
Nigeria’s Ministerial Envoy on AMR, Ayoade Alakija, said the summit will focus on translating global commitments into measurable, country-level action.
She emphasised the importance of the “One Health” approach—an integrated strategy that connects human health, animal health, agriculture, and environmental management.
Economic Stakes and Media Responsibility
Despite the scale of the crisis, experts say targeted investments could yield significant returns. Estimates suggest that every dollar invested in combating AMR could generate up to eleven times in economic benefits.
Stakeholders also stress the critical role of the media in shaping public understanding and driving accountability.
Media Mobilises: Global Awards Announced
In a move to strengthen global reporting on AMR, organisers announced the third edition of the Global AMR Media Awards 2026, alongside new regional and national categories.
Ojoma Akor unveiled Nigeria’s first-ever AMR Media Awards, aimed at boosting local journalism on the issue.
Across Asia, Kalpana Acharya confirmed the second Nepal edition, while Lata Mishra announced a similar expansion in India. Ijyaa Singh also introduced the inaugural Kerala AMR Media Awards.
Two special global categories were also launched, including a “Put People First” award announced by Vanessa Carter, designed to amplify the voices of those directly affected by drug-resistant infections.
A Defining Moment
As global attention turns to Abuja, experts say the upcoming summit represents more than a routine diplomatic gathering.
It is a decisive moment in the global fight against antimicrobial resistance—one that could shape the future of healthcare access and determine whether millions retain access to effective, life-saving treatments.
For many, the outcome may ultimately define the difference between life and death.
